Bianca Seidman

Thumb

Common double-duty heart disease treatment falls short in trial

Last week, the National Institutes of Health called an abrupt end to a medical trial expected to confirm a method doctors have already been using to combat heart disease: combining drugs to raise good cholesterol with those that lower bad cholesterol.